Overview
- Unilever’s 2025 underlying sales rose 3.5% to €50.5 billion as Beauty & Wellbeing outperformed with 4.3% growth to €12.8 billion, led by Vaseline, Dove, Nutrafol and Liquid I.V.
- Labeled a simpler, sharper company after completing its ice cream demerger, Unilever guided 2026 growth to the bottom of its 4–6% range with at least 2% volume and announced a €1.5 billion buyback.
- Unilever flagged margin pressure from higher brand investment; Liquid I.V. became a billion‑dollar brand and Olly topped $500 million in sales, with Vaseline and Dove posting double‑digit gains.
- L’Oréal’s Q4 organic sales rose 6% to about €11.25 billion and full‑year sales reached €44.05 billion like‑for‑like up 4%, with profitability improving and U.S. and China recovering in the second half.
- L’Oréal shares fell around 6% after a slight sales miss and North Asia softness, even as the group touted 2026 confidence and highlighted 2025 dealmaking including the Kering Beauté agreement and a larger Galderma stake.